Trial Information

Summary: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Double-Blind, Parallel-Group, Placebo Controlled, Safety and Efficacy Study of Adjunctive Brivaracetam in Subjects (>= 16 to 70 Years Old) With Partial Onset Seizures

New treatments should be made available to epileptic patients. Studies using brivaracetam in adults with epilepsy have shown promising results. This study will confirm the efficacy and safety of brivaracetam to support the submission file in the indication of adjunctive treatment in adolescents and adults with partial onset seizures.

Inclusion Criteria:

• Male or female between 16 and < 70 years.
• Focal epilepsy.
• Refractory patients
• No more than 2 concomitant AEDs.

Exclusion Criteria:

• Presence of clusters/Status epilepticus
• Progressive CNS disorder
• Other serious uncontrolled disease

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: March 18, 2008 at 3:03:20 PM